Zarzio (IP) sol inj 48 mio U/0.5ml, , Zarzio (IP) sol inj 48 mio U/0.5ml ser pré 5 pce

7680694050029 CH-69405 L03AA02
Zarzio (IP) sol inj 48 mio U/0.5ml, , Zarzio (IP) sol inj 48 mio U/0.5ml ser pré 5 pce
Zarzio (IP) sol inj 48 mio U/0.5ml, , Zarzio (IP) sol inj 48 mio U/0.5ml ser pré 5 pce
Zarzio (IP) sol inj 48 mio U/0.5ml, , Zarzio (IP) sol inj 48 mio U/0.5ml ser pré 5 pce
1 / 3
google

Details

GTIN
7680694050029
Pharmacode
-
Product number
-
CPT
-
Packaging group
-
Unit
-

Articles (1)

Zarzio 48 MU/0,5 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
08/07/2025
Professional SmPC
Français
08/07/2025

Detailed composition

Substance Quantity Type Category
filgrastimum
0.48 MG Substance Wirkstoff (Principe actif)
filgrastimum
- Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 401.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2024

Authorization holder

Pharma Nova GmbH

6340 Baar

Authorization information

Swissmedic authorization number
69405
Drug name
Zarzio, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L03AA02
Authorization status
Revoked/Withdrawn
Authorization category
Category P
Dispensation category
A
First authorization
07/03/2024
Authorization expiration date
11/12/2025
IT number
06.07.3.
Domain
Human medicine
Field of application
Neutropenie

Packaging details

Description (FR)
ZARZIO (IP-NOVA) 48 mio U/0.5ml ser pré 5 pce
Description (DE)
ZARZIO (PI-NOVA) 48 Mio E/0.5ml Fertspr 5 Stk
Market launch
07/03/2024
Market withdrawal
30/07/2025
Narcotic (BTM)
No

Other packaging sizes

ZARZIO (IP-NOVA) 30 mio U/0.5ml ser pré 5 pce
5 FESP
View
Buy us a coffee Explore the data